Cargando…

COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report

This article reports a case of a 21-year-old woman with refractory B-cell acute lymphocytic leukaemia who presented with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). She remained positive for SARS-CoV-2 by viral culture for 78 days and by polymerase chain reaction (PCR) for 97 days....

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Wayne F., Chorlton, Samuel, Tyson, John, Al-Rawahi, Ghada N., Jassem, Agatha N., Prystajecky, Natalie, Masud, Shazia, Deans, Gregory D., Chapman, Michael G., Mirzanejad, Yazdan, Murray, Melanie C.M., Wong, Patrick H.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553657/ https://www.ncbi.nlm.nih.gov/pubmed/34757008 http://dx.doi.org/10.1016/j.ijid.2021.10.045

Ejemplares similares

Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline
por: Kuchinski, Kevin S., et al.
Publicado: (2020)

Experience with High Dose Once-daily Vancomycin for Patients with Skin and Soft-tissue infections in an Ambulatory Setting
por: Wong, Maggie, et al.
Publicado: (2017)

750 Effectiveness, Safety, and Impact on Healthcare Decongestion by a Busy Canadian Infusion Centre for Outpatient Parenteral Antimicrobial Therapy
por: Afra, Kevin, et al.
Publicado: (2014)

Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens
por: Kuchinski, Kevin S., et al.
Publicado: (2022)

Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

2632. Duration of viable SARS-CoV-2 shedding in immunocompromised COVID-19 patients during the widespread vaccination era
por: Kanai, Osamu, et al.
Publicado: (2023)

Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)
por: Caza, Mélissa, et al.
Publicado: (2021)

Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada
por: Fibke, Chad D., et al.
Publicado: (2022)

1361. The association between antibody responses and prolonged viable SARS-CoV-2 shedding in immunocompromised patients: a prospective cohort study
por: Lim, So Yun, et al.
Publicado: (2023)

Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study
por: Olmstead, Andrea D., et al.
Publicado: (2022)

Infectious Norovirus Is Chronically Shed by Immunocompromised Pediatric Hosts
por: Davis, Amy, et al.
Publicado: (2020)

Laboratory Exposures from an Unsuspected Case of Human Infection with Brucella canis
por: Ahmed-Bentley, Jasmine, et al.
Publicado: (2021)

Successful treatment of suspected early form of chronic Chagas cardiomyopathy: a case report
por: Lu, Nelson, et al.
Publicado: (2022)

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
por: Aydillo, Teresa, et al.
Publicado: (2020)

The shedding of viable cells into the local lymph by tumours growing in the gut of rats.
por: Gyure, L. A., et al.
Publicado: (1985)

Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers
por: Murata, Takayuki, et al.
Publicado: (2021)

Viable virus shedding during SARS-CoV-2 reinfection
por: Letizia, Andrew G, et al.
Publicado: (2021)

Long-term Shedding of Influenza A Virus in Stool of Immunocompromised Child
por: Pinsky, Benjamin A., et al.
Publicado: (2010)

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
por: Prescott, Joseph, et al.
Publicado: (2018)

Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient
por: Nakajima, Yukiko, et al.
Publicado: (2021)

278. Immunocompromised Patients with Prolonged Viral Shedding of SARS-COV-2
por: Tarabay, Jessica, et al.
Publicado: (2021)

Pyelonephritis and Bacteremia Caused by Klebsiella variicola following Renal Transplantation
por: Lo, Cody, et al.
Publicado: (2021)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Clinical scoring system to predict viable viral shedding in patients with COVID-19
por: Kang, Sung Woon, et al.
Publicado: (2022)

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2021)

Prolonged Influenza Virus Shedding and Emergence of Antiviral Resistance in Immunocompromised Patients and Ferrets
por: van der Vries, Erhard, et al.
Publicado: (2013)

Duration of viable virus shedding in SARS-CoV-2 omicron variant infection
por: Boucau, Julie, et al.
Publicado: (2022)

Extraction and Detection of Avian Influenza Virus From Wetland Sediment Using Enrichment-Based Targeted Resequencing
por: Tindale, Lauren C., et al.
Publicado: (2020)

Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January–April 2021
por: Hogan, Catherine A., et al.
Publicado: (2021)

SARS-CoV-2 late shedding may be infectious between immunocompromised hosts
por: Kaila, Ville, et al.
Publicado: (2021)

Phosphatidylinositol 4-kinase is a viable target for the radical cure of Babesia microti infection in immunocompromised hosts
por: Ji, Shengwei, et al.
Publicado: (2022)

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
por: Avanzato, Victoria A., et al.
Publicado: (2020)

Spontaneous shedding of TSTA by viable sarcoma cells: its possible role in facilitating metastatic spread.
por: Currie, G. A., et al.
Publicado: (1974)

2424. Shedding of Viable Clostridiodes difficile in Patients Admitted to a Medical Intensive Care Unit
por: Young, Vincent B, et al.
Publicado: (2019)

Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region
por: Jassem, Agatha N., et al.
Publicado: (2016)

SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
por: Raglow, Zoe, et al.
Publicado: (2023)

Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient
por: Shoji, Kosuke, et al.
Publicado: (2022)

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
por: Li, Fang Fang, et al.
Publicado: (2022)

Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2022)

Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase
por: Xu, D., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_f0nmj4dpm17kj0ooib0315pdfs